Home
Statistics
How It Works
Login
Register
Keyword Connections
-
pharmaceuticals
Keywords
Connection Type
Connection
Journals
Scientific reports
regulatory toxicology and pharmacology : rtp
Environmental science and pollution research international
Environmental pollution (Barking, Essex : 1987)
PloS one
Environment international
Journal of medical Internet research
nature reviews gastroenterology & hepatology
The Science of the total environment
water science and technology : a journal of the international association on water pollution research
Journal of applied microbiology
Social science & medicine (1982)
journal of experimental psychology applied
globalization and health
health and human rights
Health economics, policy, and law
georgian medical news
Critical reviews in toxicology
Health affairs (Project Hope)
journal of the optical society of america a, optics, image science, and vision
bjs open
BMJ (Clinical research ed.)
Research Groups
No Research Group Connected
Bibliographies
[1]
A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
[2]
A Synchronized Prescription Refill Program Improved Medication Adherence.
[3]
Alcohol: taking a population perspective.
[4]
The Impact Of Price Regulation On The Availability Of New Drugs In Germany.
[5]
8-Hydroxyquinoline-5-sulfonamides are promising antifungal candidates for the topical treatment of dermatomycosis.
[6]
The accessibility of data on environmental risk assessment of pharmaceuticals - are environmental risk assessments information on emissions with respect to international and European environmental information law?
[7]
Global variation in anastomosis and end colostomy formation following left-sided colorectal resection.
[8]
[COSMETOLOGICAL SERVICES: COMPARATIVE AND LEGAL ANALYSIS].
[9]
[SPECIFIC FEATURES OF TAXATION IN UKRAINE FOR OPERATIONS ON THE SUPPLY OF HEALTH CARE SERVICES].
[10]
THE CHALLENGES OF LEGAL REGULATION OF PUBLIC PROCUREMENT OF MEDICINES AND MEDICAL PRODUCTS IN UKRAINE.
[11]
The Universal Periodic Review: A Valuable New Procedure for the Right to Health?
[12]
Health and Human Rights' Past: Patinating Law's Contribution.
[13]
The Gambia's Political Transition to Democracy: Is Abortion Reform Possible?
[14]
From the Grassroots to the Oireachtas: Abortion Law Reform in the Republic of Ireland.
[15]
The Role of Reproductive Justice Movements in Challenging South Korea's Abortion Ban.
[16]
Non-marital Pregnancies and Unmarried Women's Search for Illegal Abortion in Morocco.
[17]
Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework.
[18]
Calibration of high dynamic range images for applied color and lighting research.
[19]
Mineral oil in food, cosmetic products, and in products regulated by other legislations.
[20]
Pension and state funds dominating biomedical R&D investment: fiduciary duty and public health.
[21]
Pharmaceuticals and trace metals in the surface water used for crop irrigation: Risk to health or natural attenuation?
[22]
Insight into the removal process mechanism of pharmaceutical compounds and dyes on plasma-modified biomass: the key role of adsorbate specificity.
[23]
Adsorption of Cr(VI) and Cu(II) from aqueous solutions by biochar derived from Chaenomeles sinensis seed.
[24]
Irreversible sorption of Pb(II) from aqueous solution on breadfruit peel to mitigate environmental pollution problems.
[25]
Treatment technologies for emerging contaminants in wastewater treatment plants: A review.
[26]
choice, purchase and consumption of drugs: sociological research experience
[27]
regulating direct-to-consumer advertising of prescription drugs in the digital age
[28]
simultaneous determination of 24 antidepressant drugs and their metabolites in wastewater by ultra-high performance liquid chromatography–tandem mass spectrometry
[29]
off the shelf fouling management
[30]
bioremediation kinetics of pharmaceutical industrial effluent
[31]
The 'Netflix plus model': can subscription financing improve access to medicines in low- and middle-income countries?
[32]
How the Avengers assemble: Ecological modelling of effective cast sizes for movies.
[33]
Comparison of advanced biological treatment and nature-based solutions for the treatment of pharmaceutically active compounds (PhACs): A comprehensive study for wastewater and sewage sludge.
[34]
Results and Methodological Implications of the Digital Epidemiology of Prescription Drug References Among Twitter Users: Latent Dirichlet Allocation (LDA) Analyses.
[35]
When I use a word . . . Medical slang: gomers and gomerettes.
[36]
Possible use of a Nicotiana tabacum ‘Bright Yellow 2’ cell suspension as a model to assess phytotoxicity of pharmaceuticals (diclofenac)
[37]
Removal of pharmaceuticals by powdered activated carbon adsorption: Effect of particle size and point of addition
[38]
Extraction and determination of trace amounts of three anticancer pharmaceuticals in urine by three-phase hollow fiber liquid-phase microextraction based on two immiscible organic solvents followed by high-performance liquid chromatography.
[39]
Human health risk assessment of pharmaceuticals in treated wastewater reused for non-potable applications in Sharjah, United Arab Emirates.
[40]
Seasonal and spatial variations of pharmaceuticals and personal care products occurrence and human health risk in drinking water - A case study of China.
[41]
Concurrence of antibiotic resistant bacteria (ARB), viruses, pharmaceuticals and personal care products (PPCPs) in ambient waters of Guwahati, India: Urban vulnerability and resilience perspective.
[42]
An evaluation on the intra-day dynamics, seasonal variations and removal of selected pharmaceuticals and personal care products from urban wastewater treatment plants
[43]
A qualitative approach to assess innovation in small infant industries within developing countries: The case of pharmaceuticals in Tunisia<sup>†</sup>
[44]
Pharmaceuticals and Medical Devices: Business Practices.
[45]
The removal of pharmaceuticals during wastewater treatment: Can it be predicted accurately?
[46]
Characterization of recombinant laccase from Trametes versicolor synthesized by Arxula adeninivorans and its application in the degradation of pharmaceuticals
[47]
Bioaccumulation behaviour of pharmaceuticals and personal care products in a constructed wetland.
[48]
Novel Magnetic Carbon Nanotube-TiO <inf>2</inf> Composites for Solar Light Photocatalytic Degradation of Pharmaceuticals in the Presence of Natural Organic Matter
[49]
First nationwide investigation and environmental risk assessment of 72 pharmaceuticals and personal care products from Sri Lankan surface waterways.
[50]
Influence of leadership at top level management in achieving operational excellence in pharmaceuticals
[51]
Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021.
[52]
Pharmaceutical Creep: U.S. Military Power and the Global and Transnational Mobility of Psychopharmaceuticals.
[53]
Correction to: Biosynthesis and production of quercitols and their application in the production of pharmaceuticals: current status and prospects (Applied Microbiology and Biotechnology, (2018), 102, 11, (4641-4651), 10.1007/s00253-018-8972-y)
[54]
Microbiological testing of pharmaceuticals and cosmetics in Egypt Applied microbiology
[55]
An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals
[56]
An Industry Perspective on Forced Degradation Studies of Biopharmaceuticals: Survey Outcome and Recommendations.
[57]
Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals.
[58]
Stability aspects of preformulation and formulation of solid pharmaceuticals
[59]
Approaches to pre-formulation R and D for phytopharmaceuticals emanating from herb based traditional Ayurvedic processes
[60]
The accessibility of data on environmental risk assessment of pharmaceuticals - are environmental risk assessments information on emissions with respect to international and European environmental information law?
[61]
Generic gas chromatography flame ionization detection method using hydrogen as the carrier gas for the analysis of solvents in pharmaceuticals.
[62]
Plastic Scintillator-Based Microfluidic Devices for Miniaturized Detection of Positron Emission Tomography Radiopharmaceuticals.
[63]
Errors in particle size and concentration analysis of pharmaceuticals
[64]
Role of continuous flow processes in green manufacturing of pharmaceuticals and specialty chemicals
[65]
A Simple Colorimetric Method for the Determination of Raloxifene Hydrochloride in Pharmaceuticals Using Modified Romini's Reagent.
[66]
Pharmaceuticals in source separated sanitation systems: Fecal sludge and blackwater treatment
[67]
Correction to: Occurrence of 25 pharmaceuticals in Taihu Lake and their removal from two urban drinking water treatment plants and a constructed wetland (Environmental Science and Pollution Research, (2017), 24, 17, (14889-14902), 10.1007/s11356-017-8830-y)
[68]
Ecological risk assessment of fifty pharmaceuticals and personal care products (PPCPs) in Chinese surface waters: A proposed multiple-level system.
[69]
EANM guideline on the validation of analytical methods for radiopharmaceuticals.
[70]
A scale-down cross-flow filtration technology for biopharmaceuticals and the associated theory.
[71]
Pharmaceuticals and trace metals in the surface water used for crop irrigation: Risk to health or natural attenuation?
[72]
Spectrophotometric determination of dothiepin hydrochloride in pharmaceuticals through ion-pair complexation reaction
[73]
Cryptopharmaceuticals: Increasing the Safety of Medication by a Blockchain of Pharmaceutical Products.
[74]
Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology.
[75]
Green, Hydrothermal Synthesis of Fluorescent Carbon Nanodots from Gardenia, Enabling the Detection of Metronidazole in Pharmaceuticals and Rabbit Plasma
[76]
Recent advances in Pharmacology and Toxicology of Phytopharmaceuticals
[77]
pathogens and pharmaceuticals pollutants as indicators of contamination at the northeasthern aquifer of quintana roo.
[78]
voltammetric determination of sulfadoxine and its application in pharmaceuticals and urine samples
[79]
synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
[80]
spectrophotometric determination of l-ascorbic acid in pharmaceuticals based on its oxidation by potassium peroxymonosulfate and hydrogen peroxide
[81]
emerging security challenges to africa: the case of haphazard disposal of pharmaceuticals in ghana
[82]
effects of mixture of pharmaceuticals on early life stages of tench (tinca tinca)
[83]
pet radiopharmaceuticals for imaging integrin expression: tracers in clinical studies and recent developments
[84]
severe drug eruptions due to lamotrigine in japan based on data from the relief system of the pharmaceuticals and medical devices agency
[85]
titrimetric and spectrophotometric assay of oxcarbazepine in pharmaceuticals using n-bromosuccinimide and bromopyrogallol red
[86]
pharmaceuticals—special issue on radiopharmaceutical chemistry between imaging and endoradiotherapy
[87]
applications of yeast synthetic biology geared towards the production of biopharmaceuticals
[88]
spectrophotometric determination of zidovudine in pharmaceuticals based on charge-transfer complexation involving n-bromosuccinimide, metol and sulphanilic acid as reagents
[89]
low-level determination of residual methyl methane sulfonate and ethyl methane sulfonate in pharmaceuticals by gas chromatography with mass spectrometry
[90]
Advances in the chemical constituents and chemical analysis of Ginkgo biloba leaf, extract, and phytopharmaceuticals.